En esta página
01ACHV precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
ACHV Achieve Life Sciences, Inc. - Common Shares
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 11, 2026
$7,24
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$2,62mínimo 52 semanas
$8,64máximo 52 semanas
Capitalización Bursátil (MRQ)
$744M
P/E
-4.0
BPA
$-1.25
tus insignias
Rango 52S
$3–$9
Calificación del Analista
BUY
Precio Objetivo
$14
P/E
-4.0
ROE
·
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
ACHV Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$7.24
Capitalización Bursátil (MRQ)
$744M
P/E
-4.0
BPA
$-1.25
Rango 52S
$3–$9
ACHV Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 31 de julio de 2020 | 1-for-20 | Inversa |
| 24 de mayo de 2018 | 1-for-10 | Inversa |
| 3 de agosto de 2017 | 1-for-11 | Inversa |
| 21 de agosto de 2008 | 1-for-18 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos·2018-12-31 → 2019-12-31
BPA$-1.252020-12-31 → 2025-12-31
Flujo de caja libre·2016-12-31 → 2023-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | ACHV | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -4.0promedio 5A ≈-2.4 | ≈-2.4 | · | · | |
| P/C (MRQ) | -50.7promedio 5A ≈-17.3 | ≈-17.3 | · | · | |
| Precio / Valor Contable Tangible (MRQ) | -48.6promedio 5A ≈7.6 | ≈7.6 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | ACHV | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 1.0promedio 5A ≈5.4 | ≈5.4 | 10.9 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-54.8%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 6, 2026 | $-0.80 | $-0.16 | -405.7% |
| 31 de marzo de 2026 | May 11, 2026 | $-0.19 | $-0.31 | 39.6% |
| 31 de diciembre de 2025 | $-0.28 | $-0.28 | -1.1% | |
| 30 de septiembre de 2025 | $-0.28 | $-0.26 | -6.7% | |
| 30 de junio de 2025 | $-0.37 | $-0.37 | 0.35% | |
| 31 de marzo de 2025 | $-0.37 | $-0.37 | 0.16% | |
| 31 de diciembre de 2024 | $-0.36 | $-0.33 | -10.3% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | |
| R&D Expense | · | $23M | $16M | $30M | $24M | $7M | $10M | $6M | |
| SG&A Expense | · | $16M | $11M | $11M | $9M | $8M | $7M | $7M | |
| Operating Expenses | $55M | $39M | $27M | $41M | $33M | $15M | $17M | $13M | |
| Interest Expense | · | · | $3M | $2M | · | · | · | · | |
| Interest Income | $1M | $2M | $825.0K | $199.0K | $17.0K | $69.0K | $170.0K | $171.0K | |
| Other Non-op | $-36.0K | $-30.0K | $-9.0K | $40.0K | $-75.0K | $-49.0K | $-37.0K | $-45.0K | |
| Pretax Income | $-55M | $-40M | $-30M | $-42M | $-33M | $-15M | $-16M | $-13M | |
| Net Income | $-55M | $-40M | $-30M | $-42M | $-33M | $-15M | $-16M | $-13M | |
| EPS (Basic) | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 | $-5.42 | · | · | |
| EPS (Diluted) | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 | $-5.42 | · | · | |
| Shares (Basic) | 43,594,652 | 32,071,146 | 19,827,534 | 10,593,034 | 8,119,836 | 2,718,909 | · | · | |
| Shares (Diluted) | 43,594,652 | 32,071,146 | 19,827,534 | 10,593,034 | 8,119,836 | 2,718,909 | · | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $13M | $16M | $25M | $43M | $36M | $17M | $10M | |
| Short-term Investments | $15M | $22M | · | · | · | · | · | $5M | |
| Receivables | · | · | · | · | · | · | $8.0K | $7.0K | |
| Prepaid Expense | · | $2M | $1M | $2M | $1M | $1M | $670.0K | $926.0K | |
| Current Assets | $40M | $36M | $17M | $27M | $45M | $37M | $17M | $16M | |
| PP&E (Net) | $3.0K | $8.0K | $13.0K | $4.0K | $15.0K | $42.0K | $57.0K | $35.0K | |
| PP&E (Gross) | $256.0K | $256.0K | $256.0K | $303.0K | $302.0K | $674.0K | $657.0K | $755.0K | |
| Accum. Depreciation | $253.0K | $248.0K | $243.0K | $299.0K | $287.0K | $632.0K | $600.0K | $720.0K | |
| Goodwill | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Intangibles | $751.0K | $974.0K | $1M | $1M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | · | · | · | · | · | $187.0K | $187.0K | $118.0K | |
| Total Assets | $42M | $39M | $19M | $30M | $48M | $40M | $21M | $19M | |
| Accounts Payable | · | $2M | $618.0K | $2M | $841.0K | $332.0K | $859.0K | $144.0K | |
| Current Liabilities | $9M | $7M | $21M | $22M | $5M | $3M | $3M | $3M | |
| Capital Leases | $5.0K | $66.0K | $6.0K | $69.0K | $4.0K | $77.0K | $159.0K | $12.0K | |
| Total Liabilities | $20M | $18M | $21M | $22M | $19M | $3M | $3M | $3M | |
| Common Stock | $121.0K | $103.0K | $90.0K | $87.0K | $79.0K | $76.0K | $41.0K | $18.0K | |
| Retained Earnings | $-260M | $-206M | $-166M | $-136M | $-94M | $-60M | $-46M | $-25M | |
| AOCI | $10.0K | $31.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Stockholders' Equity | $22M | $21M | $-1M | $8M | $28M | $37M | $18M | $16M | |
| Liabilities + Equity | $42M | $39M | $19M | $30M | $48M | $40M | $21M | $19M | |
| Shares Outstanding | 53,233,988 | 34,685,072 | 21,165,760 | 17,897,029 | 9,453,542 | 6,111,735 | 1,474,258 | 6,721,117 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $228.0K | $229.0K | $228.0K | $236.0K | $250.0K | $255.0K | · | · | |
| Stock-based Comp | $9M | $5M | $3M | $3M | $2M | $1M | $1M | $854.0K | |
| Amort. of Intangibles | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | |
| Operating Cash Flow | $-49M | $-30M | $-24M | $-38M | $-29M | $-13M | $-15M | $-11M | |
| CapEx | $3.0K | · | $21.0K | · | · | $17.0K | $53.0K | $46.0K | |
| Investing Cash Flow | $6M | $-22M | $-21.0K | · | · | $-17.0K | $5M | $-5M | |
| Financing Cash Flow | $52M | $49M | $15M | $19M | $37M | $33M | $17M | $20M | |
| Net Change in Cash | $8M | $-3M | $-9M | $-18M | $7M | $19M | $7M | $4M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | · | · | $-24M | · | · | $-13M | $-15M | $-11M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -137.3% | -120.8% | · | -75.5% | -48.0% | -81.6% | -87.6% | |
| ROE | · | -152.4% | -2302.3% | · | -105.7% | -46.8% | -125.2% | -84.7% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 5.5 | 0.8 | · | 9.8 | 12.6 | 6.0 | 4.8 | |
| Quick Ratio | · | 5.1 | 0.7 | · | 9.5 | 12.2 | 5.8 | 4.5 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 0.0 | 0.0 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $0.60 | $-0.07 | · | $2.97 | $6.10 | $0.61 | $2.35 | |
| Cash Flow / Share | · | $-0.93 | $-1.23 | · | · | · | · | · | |
| Cash / Share | · | $0.37 | $0.73 | · | $4.55 | $5.87 | $0.57 | $1.42 | |
| EPS (TTM) | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 | $-5.42 | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | $0 | $0 | |
| Net Income TTM | $-55M | $-40M | $-30M | $-42M | $-33M | $-15M | $-16M | $-13M | |
| Market Cap | · | $122M | $87M | · | $74M | $50M | $313M | $163M | |
| P/E | -4.0 | -2.8 | -2.7 | -0.6 | -1.9 | -1.5 | · | · | |
| P/B | · | 5.8 | -60.2 | · | 2.6 | 1.3 | 17.3 | 10.3 | |
| P / Tangible Book | 13.4 | 6.5 | · | 7.5 | 2.9 | 1.4 | · | · | |
| P / Cash Flow | · | -4.1 | -3.6 | · | -2.5 | -3.7 | -20.5 | -15.3 | |
| P / FCF | · | · | -3.6 | · | · | -3.7 | -20.5 | -15.2 | |
| Earnings Yield | -25.1% | -35.2% | -36.4% | -163.3% | -52.4% | -66.9% | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | $5M | $7M | $7M | · | $8M | $5M | $3M | $4M | $5M | $6M | $10M | $7M | $4M | |
| SG&A Expense | · | · | · | $9M | $6M | $6M | · | $5M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $18M | $10M | $15M | $15M | $13M | $13M | $12M | $12M | $8M | $6M | $7M | $8M | $9M | $13M | $10M | $7M | |
| Interest Expense | · | · | · | · | · | · | · | $366.0K | $804.0K | $813.0K | $781.0K | $712.0K | $573.0K | $481.0K | $404.0K | $357.0K | |
| Interest Income | $1M | $297.0K | $427.0K | $554.0K | $192.0K | $322.0K | $482.0K | $673.0K | $833.0K | $368.0K | $262.0K | $193.0K | $162.0K | $73.0K | $4.0K | $4.0K | |
| Other Non-op | $-5.0K | $-13.0K | $7.0K | $-5.0K | $-59.0K | $21.0K | $-5.0K | $-8.0K | $-2.0K | $-15.0K | $-17.0K | $-6.0K | $-3.0K | $-30.0K | $5.0K | $6.0K | |
| Net Income | $-75M | $-10M | $-15M | $-14M | $-13M | $-13M | $-12M | $-13M | $-8M | $-6M | $-7M | $-8M | $-9M | $-13M | $-10M | $-8M | |
| EPS (Basic) | $-0.80 | $-0.19 | $-0.23 | $-0.28 | $-0.37 | $-0.37 | $-0.37 | $-0.36 | $-0.25 | $-0.26 | $-0.34 | $-0.43 | $-0.50 | $-1.35 | $-1.08 | $-0.80 | |
| EPS (Diluted) | $-0.80 | $-0.19 | $-0.23 | $-0.28 | $-0.37 | $-0.37 | $-0.37 | $-0.36 | $-0.25 | $-0.26 | $-0.34 | $-0.43 | $-0.50 | $-1.35 | $-1.08 | $-0.80 | |
| Shares (Basic) | 93,510,544 | 53,381,989 | · | 51,017,662 | 34,685,072 | 34,685,072 | · | 34,355,050 | 34,318,709 | 25,048,134 | 21,127,281 | 19,048,627 | 17,917,769 | 9,693,788 | 9,647,726 | 9,458,745 | |
| Shares (Diluted) | 93,510,544 | 53,381,989 | · | 51,017,662 | 34,685,072 | 34,685,072 | · | 34,355,050 | 34,318,709 | 25,048,134 | 21,127,281 | 19,048,627 | 17,917,769 | 9,693,788 | 9,647,726 | 9,458,745 |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $28M | $21M | $32M | $52M | $13M | $13M | $10M | $15M | $66M | $20M | $25M | $17M | $18M | $29M | $36M | |
| Short-term Investments | $139M | $1M | $15M | $16M | $4M | $10M | $22M | $33M | $47M | · | · | · | · | · | · | · | |
| Prepaid Expense | · | · | · | $2M | $2M | $2M | · | $3M | $1M | $1M | $2M | $958.0K | $2M | $3M | $1M | $1M | |
| Current Assets | $188M | $31M | $40M | $50M | $57M | $25M | $36M | $46M | $63M | $68M | $22M | $26M | $18M | $21M | $31M | $38M | |
| PP&E (Net) | · | · | $3.0K | · | · | · | $8.0K | · | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | · | · | $256.0K | · | · | · | $256.0K | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $253.0K | · | · | · | $248.0K | · | · | · | · | · | · | · | · | · | |
| Goodwill | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Intangibles | $640.0K | $696.0K | $751.0K | $807.0K | $863.0K | $918.0K | $974.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | |
| Total Assets | $190M | $33M | $42M | $52M | $59M | $27M | $39M | $48M | $65M | $70M | $24M | $29M | $21M | $24M | $34M | $41M | |
| Accounts Payable | · | · | · | $2M | $1M | $2M | · | $1M | $550.0K | $373.0K | $638.0K | $361.0K | $1M | $412.0K | $656.0K | $418.0K | |
| Accrued Liabilities | $200.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $198M | $12M | $9M | $10M | $9M | $7M | $7M | $7M | $14M | $21M | $4M | $3M | $20M | $7M | $5M | $4M | |
| Capital Leases | · | · | $5.0K | $21.0K | $37.0K | $52.0K | $66.0K | · | · | · | $22.0K | $38.0K | $54.0K | · | · | · | |
| Total Liabilities | $205M | $22M | $20M | $18M | $17M | $17M | $18M | $17M | $23M | $21M | $20M | $19M | $20M | $23M | $21M | $19M | |
| Common Stock | $170.0K | $121.0K | $121.0K | $121.0K | $118.0K | $103.0K | $103.0K | $103.0K | $103.0K | $103.0K | $90.0K | $90.0K | $87.0K | $79.0K | $79.0K | $79.0K | |
| Retained Earnings | $-345M | $-270M | $-260M | $-246M | $-231M | $-218M | $-206M | $-193M | $-181M | $-172M | $-160M | $-153M | $-145M | $-125M | $-112M | $-101M | |
| AOCI | $-88.0K | $2.0K | $10.0K | $9.0K | $3.0K | $6.0K | $31.0K | $75.0K | $-7.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Stockholders' Equity | $-15M | $11M | $22M | $34M | $42M | $10M | $21M | $31M | $42M | $49M | $4M | $10M | $443.0K | $1M | $13M | $21M | |
| Liabilities + Equity | $190M | $33M | $42M | $52M | $59M | $27M | $39M | $48M | $65M | $70M | $24M | $29M | $21M | $24M | $34M | $41M | |
| Shares Outstanding | 102,717,200 | 53,240,988 | 53,233,988 | 52,812,488 | 49,685,072 | 34,685,072 | 34,685,072 | 34,389,946 | 34,341,303 | 34,251,911 | 21,165,760 | 21,105,760 | 17,930,362 | 9,710,747 | 9,681,855 | 9,473,577 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $58.0K | $57.0K | $57.0K | $54.0K | $55.0K | $62.0K | $58.0K | $57.0K | $57.0K | $57.0K | $58.0K | $55.0K | $58.0K | $55.0K | $56.0K | $60.0K | |
| Stock-based Comp | $7M | $-685.0K | $1M | $2M | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $829.0K | $840.0K | $823.0K | |
| Amort. of Intangibles | · | $100.0K | $-100.0K | $100.0K | $100.0K | $100.0K | $-100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | |
| Operating Cash Flow | $-11M | $-7M | $-18M | $-11M | $-9M | $-11M | $-9M | $-10M | $-5M | $-5M | $-5M | $-7M | $-8M | $-11M | $-8M | $-7M | |
| Investing Cash Flow | $-138M | $14M | $709.0K | $-13M | $7M | $11M | $12M | $13M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $168M | $21.0K | $6M | $4M | · | · | $682.0K | $-8M | $-153.0K | $56M | $0 | $15M | $47.0K | $146.0K | $1M | $95.0K | |
| Net Change in Cash | $20M | $7M | $-11M | $-20M | $39M | $263.0K | $3M | $-5M | $-52M | $51M | $-5M | $9M | $-8M | $-11M | $-7M | $-7M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -60.0% | -33.6% | · | -28.9% | -20.6% | -26.3% | · | -34.6% | -18.1% | -14.3% | -29.6% | -26.2% | -29.3% | -42.5% | -26.3% | -20.4% | |
| ROE | -554.0% | -97.0% | · | -44.4% | -30.3% | -43.0% | · | -70.7% | -32.6% | -26.0% | -279.7% | -72.1% | -82.2% | -73.2% | -38.8% | -29.4% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 2.6 | · | 5.1 | 6.6 | 3.5 | · | 6.8 | 4.6 | 3.3 | 5.4 | 7.7 | 0.9 | 3.0 | 5.8 | 9.4 | |
| Quick Ratio | 0.9 | 2.5 | · | 4.9 | 6.5 | 3.3 | · | 6.4 | 4.5 | 3.2 | 4.9 | 7.3 | 0.8 | 2.6 | 5.5 | 9.1 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.14 | $0.20 | · | $0.64 | $0.84 | $0.30 | · | $0.91 | $1.23 | $1.44 | $0.19 | $0.46 | $0.02 | $0.11 | $1.36 | $2.26 | |
| Cash Flow / Share | · | $-0.13 | · | · | · | $-0.32 | · | · | · | $-0.21 | · | · | $-0.46 | · | · | · | |
| Cash / Share | $0.47 | $0.53 | · | $0.60 | $1.04 | $0.38 | · | $0.28 | $0.43 | $1.94 | $0.94 | $1.19 | $0.92 | $1.87 | $3.03 | $3.84 | |
| EPS (TTM) | $-1.50 | $-1.07 | · | $-1.39 | $-1.47 | $-1.35 | · | $-1.10 | $-1.08 | $-1.26 | $-2.04 | $-3.05 | $-3.70 | $-3.92 | $-3.28 | $-3.73 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-114M | $-52M | · | $-52M | $-50M | $-46M | · | $-33M | $-28M | $-27M | $-36M | $-42M | $-44M | $-38M | $-32M | $-33M | |
| Market Cap | $671M | $157M | · | $166M | $112M | $93M | · | $163M | $161M | $156M | $91M | $110M | $122M | $32M | $47M | $72M | |
| P/E | -4.4 | -2.7 | · | -2.3 | -1.5 | -2.0 | · | -4.3 | -4.4 | -3.6 | -2.1 | -1.7 | -1.8 | -0.8 | -1.5 | -2.0 | |
| P/B | -45.7 | 14.7 | · | 4.9 | 2.7 | 9.0 | · | 5.2 | 3.8 | 3.2 | 22.5 | 11.3 | 275.2 | 30.7 | 3.6 | 3.3 | |
| P / Tangible Book | · | 17.5 | · | 5.2 | 2.8 | 11.1 | · | 5.6 | 4.0 | 3.3 | 51.9 | 14.9 | · | · | 4.5 | 3.8 | |
| P / Cash Flow | · | -22.6 | · | · | · | -8.4 | · | · | · | -29.5 | · | · | -14.7 | · | · | -10.6 | |
| Earnings Yield | -23.0% | -36.4% | · | -44.1% | -65.0% | -50.6% | · | -23.2% | -23.0% | -27.7% | -47.4% | -58.8% | -54.4% | -118.8% | -67.2% | -49.3% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-55M | $-40M | $-30M | $-42M | $-33M |
| EPS Diluido | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | · | 5.5 | 0.8 | · | 9.8 |
| Ratio Rápido | · | 5.1 | 0.7 | · | 9.5 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | · | · | $-24M | · | · |
Propietarios institucionales (13F) 123 declarantes · $548.5M total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
123
Valor en tenencia
$548.5M
Nuevas posiciones
48
Posiciones cerradas
17
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 48 (+29 vs trimestre anterior) | 17 (+8 vs trimestre anterior) | 40 (+20 vs trimestre anterior) | 14 (-9 vs trimestre anterior) | +59.9M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $49 724 879 | 7 614 836 | 9,06% | Acciones |
| TPG GP A, LLC | $44 910 597 | 6 877 580 | 8,19% | Acciones |
| venBio Partners LLC | $38 623 122 | 5 914 720 | 7,04% | Acciones |
| Logos Global Management LP | $35 425 250 | 5 425 000 | 6,46% | Acciones |
| BlackRock, Inc. | $34 426 271 | 5 272 017 | 6,28% | Acciones |
| FRANKLIN RESOURCES INC | $32 344 527 | 4 953 220 | 5,90% | Acciones |
| Paradigm Biocapital Advisors LP | $32 335 620 | 4 951 856 | 5,89% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $27 039 502 | 4 140 812 | 4,93% | Acciones |
| Propel Bio Management, LLC | $26 342 138 | 4 034 018 | 4,80% | Acciones |
| MARSHALL WACE, LLP | $24 620 145 | 3 770 313 | 4,49% | Acciones |
| STATE STREET CORP | $19 234 285 | 2 945 526 | 3,51% | Acciones |
| Venrock Adviser, LLC | $17 964 239 | 2 751 032 | 3,27% | Acciones |
| Vivo Capital, LLC | $17 964 239 | 2 751 032 | 3,27% | Acciones |
| EVENTIDE ASSET MANAGEMENT, LLC | $14 496 600 | 2 220 000 | 2,64% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $13 471 818 | 2 062 721 | 2,46% | Acciones |
| Alyeska Investment Group, L.P. | $12 574 965 | 1 925 722 | 2,29% | Acciones |
| VANGUARD GROUP INC | $12 297 331 | 2 474 312 | 2,24% | Acciones |
| Simplify Asset Management Inc. | $9 351 646 | 1 432 105 | 1,70% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $9 317 755 | 1 426 915 | 1,70% | Acciones |
| Caption Management, LLC | $7 676 015 | 1 175 500 | 1,40% | Opción de compra |
| LPL Financial LLC | $5 891 725 | 902 255 | 1,07% | Acciones |
| NORTHERN TRUST CORP | $4 856 753 | 743 760 | 0,89% | Acciones |
| Spruce Street Capital LP | $4 810 240 | 736 637 | 0,88% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $3 877 194 | 593 751 | 0,71% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3 771 075 | 577 500 | 0,69% | Opción de compra |
| RAYMOND JAMES FINANCIAL INC | $3 567 457 | 546 318 | 0,65% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3 510 502 | 537 596 | 0,64% | Acciones |
| KVP Capital Advisors, LP | $3 019 178 | 462 355 | 0,55% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $2 880 951 | 441 187 | 0,53% | Acciones |
| UBS Group AG | $2 043 916 | 313 004 | 0,37% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 515 861 | 232 138 | 0,28% | Acciones |
| Caption Management, LLC | $1 487 096 | 227 733 | 0,27% | Acciones |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1 483 472 | 227 178 | 0,27% | Acciones |
| Bank of New York Mellon Corp | $1 424 364 | 218 126 | 0,26% | Acciones |
| JANE STREET GROUP, LLC | $1 331 467 | 203 900 | 0,24% | Opción de compra |
| CITADEL ADVISORS LLC | $1 326 243 | 203 100 | 0,24% | Opción de compra |
| Nuveen, LLC | $1 248 210 | 191 150 | 0,23% | Acciones |
| BANK OF AMERICA CORP /DE/ | $1 208 540 | 185 075 | 0,22% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 162 660 | 178 049 | 0,21% | Acciones |
| WELLS FARGO & COMPANY/MN | $1 114 233 | 170 633 | 0,20% | Acciones |
| TWO SIGMA ADVISERS, LP | $1 043 203 | 209 900 | 0,19% | Acciones |
| CITADEL ADVISORS LLC | $804 032 | 123 129 | 0,15% | Acciones |
| CANTOR FITZGERALD, L. P. | $794 250 | 121 631 | 0,14% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $791 534 | 121 215 | 0,14% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $677 161 | 103 700 | 0,12% | Opción de venta |
| Shay Capital LLC | $606 049 | 92 810 | 0,11% | Acciones |
| XTX Topco Ltd | $587 896 | 90 030 | 0,11% | Acciones |
| RHUMBLINE ADVISERS | $568 253 | 87 023 | 0,10% | Acciones |
| Blue Trust, Inc. | $560 849 | 85 888 | 0,10% | Acciones |
| Diametric Capital, LP | $530 098 | 81 179 | 0,10% | Acciones |
Activistas y propietarios del %+ 5 9 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| venBio Global Strategic Fund V, L.P., venBio Global Strategic GP V, LLC | 27 de abril de 2026 | 9,99% | Presentación inicial | Inversión pasiva | SEC |
| TPG GP A, LLC, James G. Coulter, Jon Winkelried | 24 de abril de 2026 | 12,60% | Presentación inicial | Campaña de la junta directiva | SEC |
| Dialectic Capital Management, LP, Dialectic Partners, LLC, Dialectic Life Sciences SPV LLC, Dialectic LS Manager LLC, John Fichthorn ×3 presentaciones | 23 de marzo de 2023 | · | Presentación inicial | · | SEC |
| Anthony Clarke | 11 de agosto de 2017 | · | Presentación inicial | Inversión pasiva | SEC |
| Richard Stewart | 11 de agosto de 2017 | · | Presentación inicial | Inversión pasiva | SEC |
| Working Opportunity Fund (EVCC) Ltd., GrowthWorks Capital Ltd. ×5 presentaciones | 14 de febrero de 2011 | · | Presentación inicial | · | SEC |
| 28 de octubre de 2010 | · | Presentación inicial | · | SEC | |
| Abingworth LLP | 20 de agosto de 2010 | · | Presentación inicial | Inversión pasiva | SEC |
| SCHERING BERLIN VENTURE CORPORATION, SCHERING BERLIN INC., SCHERING INTERNATIONAL HOLDING GmbH, SCHERING AKTIENGESELLSCHAFT | 31 de octubre de 2005 | · | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 48 insiders · 17 directivos · 26 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Andrew D. Goldberg | CEO and President | 18 de abril de 2026 A | · | 0 | 0 | $0 |
| John Bencich | CEO | 16 de agosto de 2024 A | 100 636 | 0 | 0 | $0 |
| Mark K Oki | Chief Financial Officer | 28 de enero de 2026 A | 127 940 | 0 | 0 | $0 |
| Michelle Renee Griffin | CFO | 8 de mayo de 2012 A | · | 0 | 0 | $0 |
| Stephen Charles Anderson | CFO and Secretary | 31 de diciembre de 2009 A | 10 000 | 0 | 0 | $0 |
| Alan Fuhrman | Senior Vice President & CFO | 18 de marzo de 2008 A | · | 0 | 0 | $0 |
| Cindy Jacobs | President & CMO | 4 de septiembre de 2025 M | 115 585 | 0 | 0 | $0 |
| Mark Lawrence Rubinstein | Chief Medical Officer | 28 de enero de 2026 A | · | 0 | 0 | $0 |
| Craig Donnelly | Chief Operations Officer | 28 de enero de 2026 A | · | 0 | 0 | $0 |
| Jaime Xinos | Chief Commercial Officer | 28 de enero de 2026 A | 74 432 | 0 | 0 | $0 |
| Jerry Wann | Principal Accounting Officer | 28 de enero de 2026 A | 32 694 | 0 | 0 | $0 |
| Erik Atkisson | Chief Legal Officer | 4 de diciembre de 2025 A | · | 0 | 0 | $0 |
| Anthony Clarke | CSO | 28 de abril de 2022 M | 3 502 | 0 | 0 | $0 |
| Susan D. Wyrick | PAO | 14 de marzo de 2014 A | 1 312 | 0 | 0 | $0 |
| Cameron William Lawrence | Principal Accounting Officer | 8 de mayo de 2012 A | 950 | 0 | 0 | $0 |
| Craig Steven Eudy | Principal Accounting Officer | 29 de diciembre de 2006 A | · | 0 | 0 | $0 |
| Michael B Stewart | Sr. VP & Chief Medical Officer | 16 de diciembre de 2005 A | · | 0 | 0 | $0 |
| Richard Alistair Stewart | Consejero | 19 de agosto de 2026 S | 208 249 | 0 | 1 | $-175 115 |
| Reid Alexander Waldman | Consejero | 27 de julio de 2026 A | · | 0 | 0 | $0 |
| Christopher Nathan Martin | Consejero | 27 de julio de 2026 A | · | 0 | 0 | $0 |
| Thomas Sellig | Consejero | 27 de julio de 2026 A | · | 0 | 0 | $0 |
| Nancy R. Phelan | Consejero | 27 de julio de 2026 A | · | 0 | 0 | $0 |
| Aaron Royston | Consejero | 27 de julio de 2026 A | · | 0 | 0 | $0 |
| Jeffrey S Farrow | Consejero | 27 de julio de 2026 A | · | 0 | 0 | $0 |
| Thomas Braxton King | Consejero | 4 de septiembre de 2025 M | 315 142 | 0 | 0 | $0 |
| Kristen B. Slaoui | Consejero | 6 de junio de 2025 A | · | 0 | 0 | $0 |
| Stuart Duty | Consejero | 6 de junio de 2025 A | · | 0 | 0 | $0 |
| Bridget A Martell | Consejero | 6 de junio de 2025 A | · | 0 | 0 | $0 |
| Vaughn B Himes | Consejero | 22 de enero de 2024 A | · | 0 | 0 | $0 |
| Donald Joseph | Consejero | 31 de mayo de 2022 A | · | 0 | 0 | $0 |
| Martin A Mattingly | Consejero | 31 de mayo de 2022 A | 10 500 | 0 | 0 | $0 |
| Jay M Moyes | Consejero | 31 de mayo de 2022 A | · | 0 | 0 | $0 |
| Scott Daniel Cormack | Consejero | 12 de mayo de 2020 A | 14 810 | 0 | 0 | $0 |
| PARKER H STEWART | Consejero | 12 de mayo de 2020 A | 12 500 | 0 | 0 | $0 |
| Neil James Clendeninn | Consejero | 26 de mayo de 2016 A | 22 421 | 0 | 0 | $0 |
| Jack Goldstein | Consejero | 26 de mayo de 2016 A | 17 500 | 0 | 0 | $0 |
| David V Smith | Consejero | 26 de mayo de 2016 A | 9 500 | 0 | 0 | $0 |
| Dwight Winstead | Consejero | 17 de mayo de 2010 M | 0 | 0 | 0 | $0 |
| Patrick Robert Brady | Consejero | 22 de diciembre de 2009 M | 21 130 | 0 | 0 | $0 |
| Robert E Ivy | Consejero | 18 de mayo de 2007 M | 1 700 | 0 | 0 | $0 |
| George W Dunbar JR | Consejero | 10 de mayo de 2007 A | 3 250 | 0 | 0 | $0 |
| VENTURES WEST CAPITAL LTD | Propietario del 10% | 15 de diciembre de 2008 S | 41 763 | 0 | 0 | $0 |
| SAC CAPITAL ADVISORS LLC | Propietario del 10% | 19 de febrero de 2004 P | 1 419 752 | 0 | 0 | $0 |
| SAC CAPITAL ASSOCIATES LLC | Propietario del 10% | 19 de febrero de 2004 P | 867 376 | 0 | 0 | $0 |
| S A C CAPITAL MANAGEMENT L L C | Propietario del 10% | 19 de febrero de 2004 P | 1 419 752 | 0 | 0 | $0 |
| Steven A. Cohen | Propietario del 10% | 19 de febrero de 2004 P | 1 419 752 | 0 | 0 | $0 |
| Michael A Martino | · | 6 de julio de 2010 M | 11 000 | 0 | 0 | $0 |
| Richard J Klein | · | 29 de diciembre de 2003 A | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 13 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,78% | 56 308 NS | 31 de julio de 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,36% | 196 745 SH | 2 de octubre de 2026 | Diario |
| IWC · iShares Trust | 0,13% | 264 043 SH | 11 de septiembre de 2026 | Diario |
| LABU · Direxion Shares ETF Trust | 0,06% | 45 865 NS | 31 de julio de 2026 | N-PORT |
| IWO · iShares Trust | 0,04% | 731 016 SH | 11 de septiembre de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 83 121 SH | 19 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 447 963 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,02% | 1 986 639 SH | 11 de septiembre de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,02% | 627 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 957 103 SH | 19 de agosto de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 31 805 SH | 9 de septiembre de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3 108 369 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6 512 SH | 19 de agosto de 2026 | Diario |
ACHV Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 17 analistas
COMPRA
Objetivo mediano
$13.00
+79,6%
3 17,6%
Compra fuerte
13 76,5%
Compra
1 5,9%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
13 analistas · 2026-10-04Objetivo medio $14.15 +95,5%
← Por Debajo de Todos los Objetivos
Precio Actual $7.24
Mín$9.00
Media$14.15
Máx$21.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ACHV | · | -4.0 | · | · | · | · |
| ANNX | $750M | -3.7 | · | · | -100.7% | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
| DSGN | $567M | -7.7 | · | · | -32.8% | · |
| GERN | $845M | -10.2 | -60.2% | · | -34.4% | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
| FDMT | $432M | -3.1 | 230194.6% | -164.4% | -30.2% | · |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | · |
| SLDB | $445M | -2.8 | · | · | -79.5% | · |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | · |
| IMMX | $277M | -5.9 | · | · | -59.8% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 11, 2026